ACADIA Pharmaceuticals Inc, based in Ridgefield, CT, is a pioneering neuroscience company that has been at the forefront of healthcare for over 25 years. They are dedicated to developing innovative solutions to address unmet medical needs and elevate the lives of those in need. With FDA-approved treatments for Parkinson's Disease Psychosis and Rett syndrome, ACADIA is committed to advancing breakthroughs in neuroscience and improving the quality of life for patients.
Driven by their mission to elevate life through science, ACADIA is focused on developing novel medicines and therapies for conditions such as schizophrenia, Alzheimer's Disease Psychosis, Prader-Willi Syndrome, and neuropsychiatric symptoms in CNS disorders. With a strong commitment to addressing unmet needs in rare diseases, ACADIA strives for a healthier future by embracing diverse perspectives, fostering collaboration, and standing resilient in their dedication to improving patient outcomes.
Generated from the website